Highly sensitive C-reactive protein, body mass index, and serum lipids in HIV-infected persons receiving antiretroviral therapy: a longitudinal study.
about
Role of high-sensitivity C-reactive protein measurements in HIV patientsAngiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trialMicrovascular Endothelial Dysfunction and Enhanced Thromboxane and Endothelial Contractility in Patients with HIV.Carotid intima media thickness is associated with body fat abnormalities in HIV-infected patientsBiomarkers and HIV-associated cardiovascular disease.Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection.Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals.Impact of weight on immune cell counts among HIV-infected persons.Subclinical atherosclerosis among HIV-infected adults attending HIV/AIDS care at two large ambulatory HIV clinics in Uganda.Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohortInflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy.Serum leptin level mediates the association of body composition and serum C-reactive protein in HIV-infected persons on antiretroviral therapy.Urine Eicosanoids in the Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) Trial.Circulating interleukin-6, soluble CD14, and other inflammation biomarker levels differ between obese and nonobese HIV-infected adults on antiretroviral therapy.Sex differences in urinary biomarkers of vascular and endothelial function in HIV-infected persons receiving antiretroviral therapyAdipose tissue and immune function: a review of evidence relevant to HIV infection.The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study.An association between adiposity and serum levels of macrophage inflammatory protein-1α and soluble CD14 in HIV-infected adults: results from a cross-sectional study.Higher Body Mass Index Is Associated With Greater Proportions of Effector CD8+ T Cells Expressing CD57 in Women Living With HIV.Acupuncture to Reduce HIV-Associated Inflammation.Elevations in D-dimer and C-reactive protein are associated with the development of osteonecrosis of the hip in HIV-infected adults.C-Reactive Protein as an Independent Cardiovascular Risk Predictor in HIV+ Patients: A Focused Review of Published Studies.
P2860
Q28067891-FCDA08E0-744F-424E-ADFA-0BDEE635352EQ28484460-84CFAF6D-210A-4698-BD21-B0FD74C8F4E1Q33792101-213D2D08-B9D2-457F-88E3-B74B8DD7B0FCQ33864945-05A6ECFF-7EA7-46B6-8100-0C78F1FA7D31Q34335486-1C7544C9-63E6-4666-971B-6D0F99D748B3Q34423991-5108073B-80AC-4BFE-98BD-A5AC51E5ABA1Q34875287-2B73CC78-2490-4891-B2C3-180BFBC1208BQ35066425-F902AA59-3605-4E1F-A4B9-5A36BFE80354Q35107571-F2387F9B-7FE6-46BD-8275-C71E113E2544Q35215672-AE51A3D3-4BBF-40D5-9AE8-49F939EE83DCQ35873877-739E67F2-7AFF-40B3-A92A-224E85D5FEDCQ35979650-FF63FD2A-FA50-4FDE-997E-C9A4C8BF4308Q36258777-6BF3350C-EAF2-46EE-BB42-BE2C58A39AC1Q36937853-3E5BE7C0-3992-4A6B-B643-2C0148A662A6Q37155953-0371D222-B8A7-44B7-92A3-C43630DE17D6Q37187518-7D436B96-B063-48A0-91D2-BA3C108D3638Q37355492-EE582BA4-1985-4989-8D41-89F71D96B46AQ37581934-CB7DD997-B134-487B-A686-80E25417CAD6Q38741619-82D5721C-B268-4F2C-80CA-25768F9456D1Q39683044-52CF27B1-EF34-4749-B725-365588EAD62DQ40994937-128668AA-48DD-4FA9-B953-A70C4FA9DD9CQ42373024-D344C66B-375D-464C-8D22-A6FEAF3D5B29
P2860
Highly sensitive C-reactive protein, body mass index, and serum lipids in HIV-infected persons receiving antiretroviral therapy: a longitudinal study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Highly sensitive C-reactive pr ...... therapy: a longitudinal study.
@en
Highly sensitive C-reactive pr ...... therapy: a longitudinal study.
@nl
type
label
Highly sensitive C-reactive pr ...... therapy: a longitudinal study.
@en
Highly sensitive C-reactive pr ...... therapy: a longitudinal study.
@nl
prefLabel
Highly sensitive C-reactive pr ...... therapy: a longitudinal study.
@en
Highly sensitive C-reactive pr ...... therapy: a longitudinal study.
@nl
P2093
P2860
P1476
Highly sensitive C-reactive pr ...... therapy: a longitudinal study.
@en
P2093
Ayumi Shintani
David W Haas
Jason D Morrow
Leigh Anne Redhage
Michael S Boger
Todd Hulgan
Valerie Mitchell
P2860
P304
P356
10.1097/QAI.0B013E3181B939E5
P407
P577
2009-12-01T00:00:00Z